Adam Crystal

Companies

• Tango Therapeutics (United States)President Feb 4, 2026 to now¹
• Tango Therapeutics (United States)Officer Mar 2, 2023 to Feb 6, 2025²
• C4 Therapeutics (United States)Chief Medical Officer Oct 1, 2020 to Feb 1, 2023³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• TTTango Therapeutics (United States) TNGX115,743 shares⁴$2.6M at $22.45Sep 1, 2026
• CTC4 Therapeutics (United States) CCCC20,097 shares⁵$55.6K at $2.77Jan 30, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 1, 2026Sold 27,000 shares at $22.37 of Tango Therapeutics (United States)⁴
• Sep 1, 2026Exercised options 27,000 shares at $5.20 of Tango Therapeutics (United States)⁴
• Aug 3, 2026Sold 21,733 shares at $27.35 of Tango Therapeutics (United States)⁶
• Aug 3, 2026Sold 5,267 shares at $26.79 of Tango Therapeutics (United States)⁶
• Aug 3, 2026Exercised options 27,000 shares at $5.20 of Tango Therapeutics (United States)⁶
• Jul 1, 2026Sold 7,371 shares at $30.25 of Tango Therapeutics (United States)⁷
• Jul 1, 2026Sold 19,629 shares at $29.34 of Tango Therapeutics (United States)⁷
• Jul 1, 2026Exercised options 27,000 shares at $5.20 of Tango Therapeutics (United States)⁷
• Jun 1, 2026Sold 20,860 shares at $23.06 of Tango Therapeutics (United States)⁸
• Jun 1, 2026Sold 6,140 shares at $22.25 of Tango Therapeutics (United States)⁸
• Jun 1, 2026Exercised options 27,000 shares at $5.20 of Tango Therapeutics (United States)⁸
• May 1, 2026Sold 1,100 shares at $22.00 of Tango Therapeutics (United States)⁹
• May 1, 2026Sold 25,900 shares at $21.19 of Tango Therapeutics (United States)⁹
• May 1, 2026Exercised options 27,000 shares at $5.20 of Tango Therapeutics (United States)⁹
• Apr 15, 2026Sold 38,460 shares at $25.00 of Tango Therapeutics (United States)¹⁰
• Apr 15, 2026Exercised options 38,460 shares at $5.20 of Tango Therapeutics (United States)¹⁰
• Apr 1, 2026Sold 27,000 shares at $21.20 of Tango Therapeutics (United States)¹¹
• Apr 1, 2026Exercised options 27,000 shares at $5.20 of Tango Therapeutics (United States)¹¹
• Mar 25, 2026Sold 12,000 shares at $20.11 of Tango Therapeutics (United States)¹²
• Mar 25, 2026Exercised options 12,000 shares at $5.20 of Tango Therapeutics (United States)¹²
• Mar 5, 2026Sold 20,251 shares at $15.00 of Tango Therapeutics (United States)¹³
• Feb 25, 2026Sold 54,345 shares at $12.77 of Tango Therapeutics (United States)¹⁴
• Feb 3, 2026Sold 201 shares at $12.90 of Tango Therapeutics (United States)¹⁵
• Feb 3, 2026Sold 18,251 shares at $12.26 of Tango Therapeutics (United States)¹⁵
• Feb 2, 2026Granted 47,460 shares of Tango Therapeutics (United States)¹⁵